Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
263.32B | 268.83B | 263.83B | 252.32B | 227.44B | 280.75B | Gross Profit |
114.66B | 116.10B | 111.85B | 110.03B | 98.16B | 122.61B | EBIT |
13.62B | 14.21B | 18.16B | 22.01B | 15.37B | 29.06B | EBITDA |
15.47B | 29.78B | 29.13B | 34.56B | 29.28B | 39.77B | Net Income Common Stockholders |
6.19B | 11.91B | 13.08B | 15.89B | 12.01B | 17.59B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
144.76B | 144.66B | 130.67B | 135.09B | 140.47B | 119.70B | Total Assets |
345.21B | 349.89B | 335.22B | 337.27B | 332.03B | 334.10B | Total Debt |
49.83B | 54.43B | 49.74B | 49.73B | 53.29B | 63.03B | Net Debt |
-19.27B | -44.53B | -37.04B | -48.36B | -41.69B | -8.66B | Total Liabilities |
124.09B | 118.74B | 113.62B | 118.38B | 120.13B | 131.56B | Stockholders Equity |
221.06B | 231.15B | 221.60B | 218.90B | 211.90B | 202.54B |
Cash Flow | Free Cash Flow | ||||
0.00 | 20.60B | 293.00M | 5.45B | 16.26B | 23.16B | Operating Cash Flow |
0.00 | 30.52B | 11.34B | 16.42B | 24.59B | 33.05B | Investing Cash Flow |
0.00 | -218.00M | -3.15B | -6.10B | -3.12B | -1.70B | Financing Cash Flow |
0.00 | -21.85B | -15.23B | -19.03B | -22.95B | -24.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$1.64B | 31.08 | 3.45% | 4.16% | ― | ― | ||
62 Neutral | $11.80B | 10.37 | -7.29% | 2.91% | 7.39% | -7.96% | |
$25.26B | 10.67 | 7.85% | 2.89% | ― | ― | ||
€1.05B | 8.25 | 16.78% | 1.36% | ― | ― | ||
81 Outperform | ¥31.80B | 8.17 | 4.20% | 12.38% | 68.85% | ||
69 Neutral | ¥77.53B | 19.33 | 2.78% | 0.52% | -43.28% | ||
53 Neutral | ¥450.71B | 12.33 | ― | -6.97% | ― |